Mirae Asset Global Investments Co., Ltd. - TG THERAPEUTICS INC ownership

TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 234 filers reported holding TG THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 1.18 and the average weighting 0.1%.

Quarter-by-quarter ownership
Mirae Asset Global Investments Co., Ltd. ownership history of TG THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$715,448
-57.7%
85,580
+25.2%
0.00%
-50.0%
Q2 2023$1,690,832
+47.3%
68,373
-10.4%
0.00%
+33.3%
Q1 2023$1,148,003
+67.2%
76,330
+31.5%
0.00%
+50.0%
Q4 2022$686,448
+115.2%
58,026
+7.6%
0.00%
+100.0%
Q3 2022$319,000
+103.2%
53,927
+46.0%
0.00%
Q2 2022$157,00036,9270.00%
Other shareholders
TG THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
M28 Capital Management LP 726,200$3,086,0003.46%
Paradigm Biocapital Advisors LP 1,964,709$8,350,0001.66%
683 Capital Management, LLC 3,300,000$14,025,0000.99%
MAVERICK CAPITAL LTD 6,747,549$28,677,0000.71%
Antara Capital LP 1,500,000$6,375,0000.27%
Parkwood LLC 47,168$1,375,0000.24%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 2,677,500$11,379,0000.24%
PURA VIDA INVESTMENTS, LLC 950,813$4,041,0000.24%
OCCUDO QUANTITATIVE STRATEGIES LP 567,576$2,412,0000.20%
Antara Capital LP 900,000$3,825,0000.16%
View complete list of TG THERAPEUTICS INC shareholders